Jinxin Fertility Group Limited (FRA:3NX)

Market Cap	725.66M -12.8%
Revenue (ttm)	315.75M -8.4%
Net Income	-112.50M
EPS	-0.04
Shares Out	n/a
PE Ratio	n/a
Forward PE	19.07
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	753
Open	0.2500
Previous Close	n/a
Day's Range	0.2500 - 0.2540
52-Week Range	0.2500 - 0.4180
Beta	n/a
RSI	45.80
Earnings Date	Mar 30, 2026

About Jinxin Fertility Group

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. It offers two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. The company also provides related services, such as nutrition guidance, Chinese medicine treatment, and psycholo...

• Industry: Health Services
• Founded: 1951
• Employees: 3,365
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 3NX

Financial Performance

In 2024, Jinxin Fertility Group's revenue was 2.81 billion, an increase of 0.81% compared to the previous year's 2.79 billion. Earnings were 283.10 million, a decrease of -17.88%.

Financial numbers in CNY